Chargement en cours...
Endothelial Dysfunction in the Smokers Can Be Improved with Oral Cilostazol Treatment
BACKGROUND: Smoking is one of well known environmental factors causing endothelial dysfunction and plays important role in the atherosclerosis. We investigated the effect of cilostazol could improve the endothelial dysfunction in smokers with the measurement of flow-mediated dilatation (FMD). METHOD...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Korean Society of Echocardiography
2011
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3079080/ https://ncbi.nlm.nih.gov/pubmed/21519488 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4250/jcu.2011.19.1.21 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|